On Dec 12, 2025, Yimthin et al. from the University of Bern, Agroscope, and the International Livestock Research Institute (ILRI), published a paper in the PLOS Pathogens, titled "Capsular polysaccharide of Mycoplasma mycoides subsp. capri contributes to phenotypic diversity promoting distinctive immune responses". The article explores how surface glycans dictate the relationship between a devastating veterinary pathogen and the host immune system. The researchers demonstrate that the capsular polysaccharide (CPS) of Mycoplasma mycoides subsp. Capri (Mmc) is not merely a structural component but a sophisticated immunomodulatory tool that shields the Bacteria from detection while actively shaping the host's inflammatory landscape.

The Sugar Armor of Mycoplasma Glycan Biosynthesis Evolutionary Evasion

Glycobiology has long recognized that the cell surface is the primary interface for host-pathogen interactions. For the Mycoplasma genus, small, wall-less bacteria known for causing chronic respiratory and reproductive diseases in livestock, the absence of a peptidoglycan layer places an even greater emphasis on the plasma membrane and its associated glycans. Mmc is a particularly aggressive member of the "M. mycoides cluster," responsible for contagious agalactia and pleuropneumonia in small ruminants. While it was known that these bacteria produce a CPS primarily composed of galactofuranose, the precise functional contribution of this glycan layer to virulence and immune evasion remained enigmatic. In the realm of Synthetic Glycobiology, understanding these pathways is essential for developing next-generation glycoconjugate vaccines and antimicrobial therapies that target the "sugar coat" of pathogens.

Engineering a Capsule-Deficient Mutant via Synthetic Genomics

The research team employed advanced synthetic biology techniques to investigate the role of the CPS. Specifically, they targeted the glf gene, which encodes UDP-galactopyranose mutase, a key enzyme responsible for converting UDP-galactopyranose into UDP-galactofuranose—the building block of the Mmc capsule. Using the tandem repeat enumeration and cyanobacteria-based integration (TREC-IN) system, they successfully generated a ∆glf mutant.

The results were immediate and visually striking. When characterized via periodic acid-schiff (PAS) staining and colony blotting, the wild-type (WT) Mmc displayed robust Carbohydrate expression, whereas the ∆glf mutant showed a near-complete loss of these surface glycans. Phenotypically, the absence of the capsule led to a "transparent" colony morphology and significantly reduced the bacteria's ability to withstand environmental stressors, such as nutrient deprivation and temperature fluctuations. This experiment confirmed that the glf gene is the master regulator of galactofuranose-based CPS production and that this glycan layer is vital for the physical integrity of the pathogen.

Fig.1 Effect of different growth conditions on Mycoplasma colony size and polysaccharide presence. (Yimthin, et al., 2025)

The CPS as a Shield Against Phagocytic Clearance

The phase of the research focused on how the loss of the glycan shield affected the pathogen's interaction with host macrophages. The researchers utilized caprine monocyte-derived macrophages (MDMs) and tracked the infection process using mCherry-labeled strains.

Fig.2 Cell morphology and activation/maturation of caprine MDMs after stimulation with Mycoplasmas. (Yimthin, et al., 2025)

The findings revealed a paradoxical relationship: the capsule-deficient ∆glf mutant was phagocytosed at significantly higher rates compared to the WT strain. However, this increased uptake did not lead to more efficient clearance. Instead, the lack of CPS appeared to alter the intracellular trafficking of the bacteria. While the WT strain utilized its capsule to maintain a specific distance from the host cell membrane, a phenomenon known as "stealth" infection, the ∆glf mutant was rapidly internalized. Interestingly, the study found that the CPS-deficient mycoplasmas were more susceptible to killing within the macrophage environment, proving that the glycan layer acts as a primary defense against the cellular innate immune system. This innovation in understanding "glycan-mediated distancing" provides a new model for how mycoplasmas persist in the host.

Decoding the Transcriptomic Footprint and Immune Modulation

Perhaps the most significant discovery of the study lies in how the CPS modulates the broader immune response. The team performed RNA-sequencing (RNA-seq) on caprine peripheral blood mononuclear cells (PBMCs) stimulated with either the WT or the ∆glf mutant. The transcriptomic analysis identified hundreds of differentially expressed genes (DEGs). Most notably, the ∆glf mutant induced a much more vigorous activation of proinflammatory pathways. In experiments involving bovine plasmacytoid dendritic cells (pDCs) and natural killer (NK) cells, the absence of the capsule led to a surge in TNF-α and IFN-γ production. Furthermore, the researchers discovered that the CPS is essential for maintaining the expression of MHC-II on the surface of antigen-presenting cells. In the absence of the glycan layer, Mmc triggered a downregulation of MHC-II, effectively stalling the transition from innate to adaptive immunity. This suggests that the CPS has evolved to "tune" the host immune response, preventing over-activation that might clear the infection while simultaneously manipulating antigen presentation to ensure long-term persistence.

Fig.3 Cytokines and chemokines are secreted by PBMCs stimulated with Mycoplasmas. (Wenzel, et al., 2023)

Discussion and Innovations

• Galactofuranose as a Dual-Purpose Virulence Factor

The article demonstrates that the Mmc capsule is a multifunctional tool. It serves a structural role in environmental resilience and a biological role in immune evasion. By identifying the glf gene as the central node, the study opens the door for targeted inhibitors that could "strip" the bacteria of their protective layer, making them vulnerable to both host defenses and existing antibiotics.

• The Synthetic Genomics Advantage

The use of the TREC-IN system to create precise, scarless deletions in the Mycoplasma genome highlights the power of synthetic biology in solving classical microbiological puzzles. This approach allowed the authors to isolate the effects of a single glycan component without the confounding variables often found in traditional chemical inhibition or random mutagenesis.

Chassis Development at CD BioGlyco

Conclusion

This research provides a definitive look at the glycobiology of Mmc, establishing the CPS as a cornerstone of its pathogenic strategy. By proving that the loss of galactofuranose glycans leads to impaired antigen presentation, increased phagocytosis, and altered cytokine signaling, Yimthin and colleagues have identified a major "Achilles' heel" for this pathogen. These findings have profound implications for veterinary medicine, suggesting that CPS-targeted vaccines could provide superior protection by preventing the "immune masking" that characterizes mycoplasmal infections. As we move further into the era of synthetic glycobiology, this study stands as a testament to the importance of the bacterial glycome in defining the outcome of host-pathogen conflicts.